Showing 1 - 2 results of 2 for search 'G. S. Sonke', query time: 0.01s Refine Results
  1. 1
    The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy

    The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy by M.C. Van Maaren, T.A. Hueting, D.J.P. van Uden, M. van Hezewijk, L. de Munck, M.A.M. Mureau, P.A. Seegers, Q.J.M. Voorham, M.K. Schmidt, G.S. Sonke, C.G.M. Groothuis-Oudshoorn, S. Siesling

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial

    Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial by S. L. Aronson, B. Thijssen, M. Lopez-Yurda, S. N. Koole, P. van der Leest, A. León-Castillo, R. Harkes, I. M. Seignette, J. Sanders, M. Alkemade, I. Kemper, M. J. Holtkamp, I. A. M. Mandjes, A. Broeks, M. J. Lahaye, M. A. Rijlaarsdam, D. van den Broek, L. F. A. Wessels, H. M. Horlings, W. J. van Driel, G. S. Sonke

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: